
    
      12 healthy participants will randomly be allocated to receive levcromakalim or placebo on to
      different days efter oral glibenclamide administration.

      The aim of the study is to investigate the effect of levcromakalim/placebo infusion on
      cranial arteries after glibenclamide administration.

      Repeated magnetic resonance angiography (MRA) measurements covering the middle meningeal
      artery (MMA), superficiel temporal artery (STA) and middle cerebral artery (MCA) before and
      after glibenclamide administration and levcromakalim/placebo infusion.
    
  